Future of Targeting EGFR Exon 20 Insertion Mutations in NSCLC

Before closing out his discussion on novel therapy in EGFR exon 20 insertion–positive NSCLC, expert Joel Neal, MD, PhD, highlights ongoing clinical trials and the importance of testing. Read the transcript and/or watch the video here.